These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 10377874

  • 1. [Histochrome, a new antioxidant, in the treatment of ocular diseases].
    Egorov EA, Alekhina VA, Volobueva TM, Fedoreev SA, Mishchenko NP, Kol'tsova EA.
    Vestn Oftalmol; 1999; 115(2):34-5. PubMed ID: 10377874
    [Abstract] [Full Text] [Related]

  • 2. [The results of research on the antioxidant emoksipin in clinical eye diseases].
    Egorov EA, Shvedova AA, Obraztsova IA.
    Vestn Oftalmol; 1989; 105(5):52-5. PubMed ID: 2595902
    [Abstract] [Full Text] [Related]

  • 3. [Clinical rationale for the efficiency of using the domestic antioxidant agent Histochrome].
    Guseva MR, Beslaneeva MB.
    Vestn Oftalmol; 2010; 126(3):37-40. PubMed ID: 20608199
    [Abstract] [Full Text] [Related]

  • 4. [Pavlyuk--antioxidant "Gistochrom" in the complex treatment of intraocular hemorrhages in children].
    Guseva MR, Chinenov IM, Shirshov MV, Gorbunova ED, Pavliuk AIu.
    Vestn Oftalmol; 2005; 121(2):24-8. PubMed ID: 15881152
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Antioxidative activity of histochrome and some other drugs used in ophthalmology].
    Babenkova IV, Teselkin IuO, Makashova NV, Guseva MR.
    Vestn Oftalmol; 1999; 115(4):22-4. PubMed ID: 10523962
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ, McCallum RM, Branchaud B, Skalak C, Butuner Z, Ashton P.
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate.
    Küçükerdönmez C, Beutel J, Bartz-Schmidt KU, Gelisken F.
    Br J Ophthalmol; 2009 Feb; 93(2):235-9. PubMed ID: 18829633
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the role of ProKera in the management of ocular surface and orbital disorders.
    Pachigolla G, Prasher P, Di Pascuale MA, McCulley JP, McHenry JG, Mootha VV.
    Eye Contact Lens; 2009 Jul; 35(4):172-5. PubMed ID: 19474753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.